130 related articles for article (PubMed ID: 2007614)
1. Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancer.
Markmann M; Rothman R; Reichman B; Hakes T; Lewis JL; Rubin S; Jones W; Almadrones L; Hoskins W
J Cancer Res Clin Oncol; 1991; 117(2):89-90. PubMed ID: 2007614
[TBL] [Abstract][Full Text] [Related]
2. Magnesium homeostasis following chemotherapy with cisplatin: a prospective study.
Stewart AF; Keating T; Schwartz PE
Am J Obstet Gynecol; 1985 Nov; 153(6):660-5. PubMed ID: 4061536
[TBL] [Abstract][Full Text] [Related]
3. Hypomagnesemia following high-dose intracavitary cisplatin with systemically administered sodium thiosulfate.
Markman M; Cleary S; Howell SB
Am J Clin Oncol; 1986 Oct; 9(5):440-3. PubMed ID: 3776908
[TBL] [Abstract][Full Text] [Related]
4. Persistent hypomagnesemia following cisplatin chemotherapy for testicular cancer.
Schilsky RL; Barlock A; Ozols RF
Cancer Treat Rep; 1982 Sep; 66(9):1767-9. PubMed ID: 6889461
[TBL] [Abstract][Full Text] [Related]
5. [Hypomagnesemia in patients of gynecologic neoplasms following chemotherapy with cisplatin].
Li L; Huang W; Zhu B
Zhonghua Fu Chan Ke Za Zhi; 1995 Jun; 30(6):363-5. PubMed ID: 7555373
[TBL] [Abstract][Full Text] [Related]
6. [Hypomagnesemic and hypocalcemic coma, convulsions and ocular motility disorders after chemotherapy with platinum compounds].
Bachmeyer C; Decroix Y; Médioni J; Dhôte R; Benfiguig K; Houillier P; Grateau G
Rev Med Interne; 1996; 17(6):467-9. PubMed ID: 8758533
[TBL] [Abstract][Full Text] [Related]
7. Late effects of cisplatin-based chemotherapy on renal function in patients with ovarian carcinoma.
Markman M; Rothman R; Hakes T; Reichman B; Lewis JL; Rubin S; Jones W; Almadrones L; Hoskins W
Gynecol Oncol; 1991 Jun; 41(3):217-9. PubMed ID: 1869097
[TBL] [Abstract][Full Text] [Related]
8. The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery.
Hakeam HA; Breakiet M; Azzam A; Nadeem A; Amin T
Ren Fail; 2014 Nov; 36(10):1486-91. PubMed ID: 25155314
[TBL] [Abstract][Full Text] [Related]
9. [Hypomagnesemia following chemotherapy of disseminated testicular tumors].
Hida S; Nishimura K; Nishio Y; Okada Y; Okada K; Yoshida O
Hinyokika Kiyo; 1988 Jan; 34(1):52-60. PubMed ID: 2454015
[TBL] [Abstract][Full Text] [Related]
10. Hypomagnesemia after cisplatin combination chemotherapy.
Buckley JE; Clark VL; Meyer TJ; Pearlman NW
Arch Intern Med; 1984 Dec; 144(12):2347-8. PubMed ID: 6542342
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-induced hypocalcemia and hypomagnesemia.
Lyman NW; Hemalatha C; Viscuso RL; Jacobs MG
Arch Intern Med; 1980 Nov; 140(11):1513-4. PubMed ID: 7192079
[TBL] [Abstract][Full Text] [Related]
12. cis-Diamminedichloroplatinum-induced hypomagnesemia and renal magnesium wasting.
Bell DR; Woods RL; Levi JA
Eur J Cancer Clin Oncol; 1985 Mar; 21(3):287-90. PubMed ID: 4040020
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin and hypomagnesemia.
Lajer H; Daugaard G
Cancer Treat Rev; 1999 Feb; 25(1):47-58. PubMed ID: 10212589
[TBL] [Abstract][Full Text] [Related]
14. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin.
Vogelzang NJ; Torkelson JL; Kennedy BJ
Cancer; 1985 Dec; 56(12):2765-70. PubMed ID: 2413982
[TBL] [Abstract][Full Text] [Related]
15. Magnesium protects against cisplatin-induced acute kidney injury without compromising cisplatin-mediated killing of an ovarian tumor xenograft in mice.
Solanki MH; Chatterjee PK; Xue X; Gupta M; Rosales I; Yeboah MM; Kohn N; Metz CN
Am J Physiol Renal Physiol; 2015 Jul; 309(1):F35-47. PubMed ID: 25947343
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.
Makhija S; Sabbatini P; Aghajanian C; Venkatraman E; Spriggs DR; Barakat R
Gynecol Oncol; 2000 Oct; 79(1):28-32. PubMed ID: 11006026
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin and hypomagnesemia: Is it really a problem?
Gaughran G; Qayyum K; Smyth L; Davis A
Asia Pac J Clin Oncol; 2021 Dec; 17(6):478-485. PubMed ID: 33052033
[TBL] [Abstract][Full Text] [Related]
18. Chronic hypomagnesemia caused by cisplatin: effect of calcitriol.
Sutton RA; Walker VR; Halabe A; Swenerton K; Coppin CM
J Lab Clin Med; 1991 Jan; 117(1):40-3. PubMed ID: 1987306
[TBL] [Abstract][Full Text] [Related]
19. Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.
Schilsky RL; Anderson T
Ann Intern Med; 1979 Jun; 90(6):929-31. PubMed ID: 375794
[TBL] [Abstract][Full Text] [Related]
20. Refractory potassium repletion due to cisplatin-induced magnesium depletion.
Rodriguez M; Solanki DL; Whang R
Arch Intern Med; 1989 Nov; 149(11):2592-4. PubMed ID: 2818117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
